BioPharma Outfit Raises $78.5M To Advance Cancer Therapy
Silverback Therapeutics said Wednesday it raised $78.5 million in Series B financing led by U.S. Venture Partners that the biopharmaceutical company will use to advance its potential tumor therapy into clinical...To view the full article, register now.
Already a subscriber? Click here to view full article